Valuation: Optimax Holdings

Market Cap 280M 68.46M 59.33M 56.07M 50.91M 95.41M 6.57B 95.98M 669M 259M 3.33B 257M 251M 10.62B P/E 2026 *
18.9x
P/E 2027 * 16.8x
Enterprise Value 277M 67.7M 58.67M 55.45M 50.34M 94.35M 6.49B 94.92M 662M 256M 3.29B 254M 249M 10.5B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.7x
Free-Float
23.9%
Yield 2026 *
2.95%
Yield 2027 * 3.38%
08-28 Optimax Holdings Berhad Announces Appointment of Choe Shin Yee as Independent and Non Executive Director, Effective September 1, 2026 CI
08-28 Optimax Holdings Berhad Appoints Choe Shin Yee as Independent and Non Executive Member of Nomination and Remuneration Committee, Effective September 1, 2026 CI
08-28 Optimax Holdings Berhad Appoints Choe Shin Yee as Independent and Non Executive Member of Audit Committee , Effective September 1, 2026 CI
08-19 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
1 day-0.96%
1 week-0.96%
Current month-0.96%
1 month-0.96%
3 months-1.90%
6 months-0.96%
Current year-10.43%
1 week 0.52
Extreme 0.515
0.52
1 month 0.51
Extreme 0.51
0.52
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.505
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 01/12/2019
Director of Finance/CFO 38 01/09/2018
Chief Operating Officer 37 01/01/2024
Director TitleAgeSince
Director/Board Member 70 09/08/2018
Director/Board Member 37 01/12/2019
Director/Board Member 44 22/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/6/26 Buy

Chairman

97,000 0.0179%
29/5/26 Buy

Chairman

3,000 0.0006%
18/4/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-0.96% - - 68.71M
Average -0.96%
Weighted average by Cap. -0.96%

Financials

2026 *2027 *
Net sales 152M 37.16M 32.21M 30.44M 27.64M 51.8M 3.57B 52.11M 363M 140M 1.81B 140M 137M 5.76B 157M 38.5M 33.37M 31.54M 28.63M 53.66M 3.69B 53.98M 377M 145M 1.87B 145M 141M 5.97B
Net income 14.87M 3.64M 3.15M 2.98M 2.71M 5.07M 349M 5.1M 35.58M 13.75M 177M 13.67M 13.37M 564M 16.65M 4.07M 3.53M 3.34M 3.03M 5.68M 391M 5.71M 39.83M 15.39M 198M 15.3M 14.96M 632M
Net Debt -3.1M -758K -657K -621K -564K -1.06M -72.76M -1.06M -7.42M -2.87M -36.91M -2.85M -2.79M -118M -12.4M -3.03M -2.63M -2.48M -2.26M -4.23M -291M -4.25M -29.67M -11.46M -148M -11.4M -11.14M -471M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
15/09/26 MYR 0.5150 -0.96% 130,500
14/09/26 MYR 0.5200 0.00% 130,000
11/09/26 MYR 0.5200 0.00% 132,000
10/09/26 MYR 0.5200 0.00% 21,200
09/09/26 MYR 0.5200 0.00% 128,200
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5150MYR
Average target price
0.6380MYR
Spread / Average Target
+23.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OPTIMAX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!